Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Urologia Internationalis
|
March 22, 2016
Patient-Reported Experience of Modified Transperineal Template Guided Saturation Biopsy Under General Anaesthesia and without Prophylactic Catheterisation
Debashis Sarkar, Kingsley Ekwueme, Nigel Parr
Journal of Surgical Case Reports
|
June 26, 2014
The twisted diversion: a paralyzing complication
Kenneth Hiew, Richard Glendinning, Nigel Parr, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 4, 2006
Pyridone derivatives as potent and selective VLA-4 integrin antagonists
Jason Witherington, Vincent Bordas, Alessandra Gaiba, et al.
BJU International
|
December 9, 2015
Dynamic sentinel lymph node biopsy for penile cancer: a comparison between 1- and 2-day protocols
Panagiotis Dimopoulos, Panagiotis Christopoulos, Sam Shilito, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 12, 2020
Structure-based optimisation of orally active & reversible MetAP-2 inhibitors maintaining a tight 'molecular budget'
David J Hirst, Martin Brandt, Gordon Bruton, et al.
Journal of Bone Oncology
|
September 30, 2020
Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group
Janet E Brown, Catherine Handforth, Juliet E Compston, et al.
Plos One
|
September 7, 2013
BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models
Anastasia Wyce, Gopinath Ganji, Kimberly N Smitheman, et al.
Journal of Medicinal Chemistry
|
September 11, 2013
Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains
Olivier Mirguet, Romain Gosmini, Jérôme Toum, et al.
Journal of Medicinal Chemistry
|
August 13, 2021
Discovery of a Novel Bromodomain and Extra Terminal Domain (BET) Protein Inhibitor, I-BET282E, Suitable for Clinical Progression
Katherine L Jones, Dominic M Beaumont, Sharon G Bernard, et al.
Cancer Research
|
November 11, 2015
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
Sarah Picaud, Oleg Fedorov, Angeliki Thanasopoulou, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Urologia Internationalis
|
March 22, 2016
Patient-Reported Experience of Modified Transperineal Template Guided Saturation Biopsy Under General Anaesthesia and without Prophylactic Catheterisation
Debashis Sarkar, Kingsley Ekwueme, Nigel Parr
Journal of Surgical Case Reports
|
June 26, 2014
The twisted diversion: a paralyzing complication
Kenneth Hiew, Richard Glendinning, Nigel Parr, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 4, 2006
Pyridone derivatives as potent and selective VLA-4 integrin antagonists
Jason Witherington, Vincent Bordas, Alessandra Gaiba, et al.
BJU International
|
December 9, 2015
Dynamic sentinel lymph node biopsy for penile cancer: a comparison between 1- and 2-day protocols
Panagiotis Dimopoulos, Panagiotis Christopoulos, Sam Shilito, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 12, 2020
Structure-based optimisation of orally active & reversible MetAP-2 inhibitors maintaining a tight 'molecular budget'
David J Hirst, Martin Brandt, Gordon Bruton, et al.
Journal of Bone Oncology
|
September 30, 2020
Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group
Janet E Brown, Catherine Handforth, Juliet E Compston, et al.
Plos One
|
September 7, 2013
BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models
Anastasia Wyce, Gopinath Ganji, Kimberly N Smitheman, et al.
Journal of Medicinal Chemistry
|
September 11, 2013
Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains
Olivier Mirguet, Romain Gosmini, Jérôme Toum, et al.
Journal of Medicinal Chemistry
|
August 13, 2021
Discovery of a Novel Bromodomain and Extra Terminal Domain (BET) Protein Inhibitor, I-BET282E, Suitable for Clinical Progression
Katherine L Jones, Dominic M Beaumont, Sharon G Bernard, et al.
Cancer Research
|
November 11, 2015
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
Sarah Picaud, Oleg Fedorov, Angeliki Thanasopoulou, et al.
Page
of 1